Fundraising Fox

PsyMed Ventures

Venture capitalActively deploying

Berkeley · Seed–Series A

Fox Verdict
Sign up to see your fit

Investment thesis

PsyMed funds founders leveraging innovative neuroscience and frontier technologies to transform the mental and brain health landscape. The fund targets AI/ML-driven diagnostics and drug development, direct brain-computer interfaces, precision medicine approaches tailored to individual biology, novel genetic and cellular therapies beyond traditional pharmaceuticals, holistic interventions addressing biological and lifestyle factors, and digital health platforms. The investment thesis emphasizes founders who balance innovation with responsibility and profitability while addressing the mental health epidemic.

Source: firm website, verified Jul 21, 2026.

Stage
Seed–Series A
HQ
Berkeley, US
Instruments
Equity

Frequently asked questions

What stage does PsyMed Ventures invest at?
PsyMed Ventures invests at the Seed, Series A stages.
What sectors does PsyMed Ventures focus on?
PsyMed Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices, Mental Health.
Where is PsyMed Ventures located?
PsyMed Ventures is headquartered in Berkeley, US.

Similar investors

Featured in lists